Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
基本信息
- 批准号:8313641
- 负责人:
- 金额:$ 21.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:APC geneAdenomatous Polyposis ColiAdverse effectsAffectAmericanApoptosisApoptoticAsiaCancer EtiologyCarcinomaCessation of lifeChemopreventionChemopreventive AgentColectomyColorectalColorectal AdenomaColorectal CancerCurcuma longaCurcuminDevelopmentDiseaseDoseEpithelialFood AdditivesGerm-Line MutationGoalsGrowthHealthHerbImmunohistochemistryIntestinal CancerIntestinesLeadLesionMalignant NeoplasmsMeasurementMessenger RNAModelingMolecularMucous MembraneOrnithine DecarboxylasePTGS2 genePatientsPigmentsPlant RootsPolyaminesPolypsPowder dose formProliferating Cell Nuclear AntigenRandomizedRegulationReportingSpicesTdT-Mediated dUTP Nick End Labeling AssayTestingTurmeric extractadenomacyclooxygenase 2double-blind placebo controlled trialeffective therapyhigh riskindexinginsightpreventprophylacticrectalyoung adult
项目摘要
DESCRIPTION (provided by applicant): Familial adenomatous polyposis coli (FAP) is an autosomal dominant disorder due to germline mutation of the APC gene and characterized by the formation of hundreds of colorectal adenomatous polyps in young adults. Virtually all affected patients will develop colorectal cancer if prophylactic colectomy is not performed. Presently, the only effective therapy for FAP is colectomy and lifelong surveillance of the intestinal tract. Our long term goal is to discover effective chemopreventative therapy for patients with FAP, representing a model which may provide insights into the molecular regulation of the adenoma-carcinoma sequence in ordinary intestinal cancer. Curcumin is the major yellow pigment extracted from turmeric the powdered root of the herb Curcuma longa. Curcumin has long been used as a spice in Asia and is considered a safe food additive. Curcumin has been reported by our group to regress colorectal and ileal adenomas in 5 patients with FAP without side effects. Our hypothesis is that curcumin can decrease growth of rectal-ileal and the associated epithelial hyperproliferation in FAP patients. Our specific aims are to: a) administer curcumin to FAP patients in a randomized, placebo-controlled, double-blinded trial and sequentially determine rectal-ileal polyp number and size by using videoendoscopy. b) Sequentially assess in flat and polypoid rectal-ileal mucosa markers of epithelial proliferation (ornithine decarboxylase, polyamines and immunohistochemistry for proliferating cell nuclear antigen), apoptosis (apoptotic index by morphologic measurement and TUNEL assay), and cyclooxygenase- 2 levels (immunohistochemistry and qRT-PCR assessment of COX-2 mRNA). PUBLIC HEALTH RELEVANCE: Colorectal cancer is an important American health problem being the second leading cause of cancer death in the U.S. This project will assess in patients at high risk for colorectal malignancy the ability of curcumin, long used as a spice in Asia and considered a safe food additive, to prevent the development of the colorectal adenoma (the lesion that develops into colorectal cancer).
描述(由申请人提供):家族性大肠腺瘤性息肉病(FAP)是一种常染色体显性遗传病,由于APC基因的种系突变,其特征是在年轻人中形成数百个结直肠腺瘤性息肉。如果不进行预防性结肠切除术,几乎所有受影响的患者都会患上结直肠癌。目前,唯一有效的治疗FAP的方法是结肠切除术和终身监测肠道。我们的长期目标是为FAP患者发现有效的化学预防治疗,代表一个可能为普通肠癌腺瘤-癌序列的分子调控提供见解的模型。姜黄素是从姜黄中提取的主要黄色色素,姜黄是一种草本植物姜黄根的粉末。姜黄素在亚洲长期被用作香料,被认为是一种安全的食品添加剂。本组报道姜黄素治疗5例FAP患者的结直肠和回肠腺瘤,无副作用。我们的假设是姜黄素可以减少FAP患者直肠-回肠的生长和相关的上皮增生。我们的具体目标是:a)在一项随机、安慰剂对照、双盲试验中给FAP患者姜黄素,并通过视频内窥镜连续测定直肠-回肠息肉的数量和大小。b)依次评估扁平和息肉状直肠-回肠粘膜上皮细胞增殖(鸟氨酸脱羧酶、多胺和增殖细胞核抗原的免疫组织化学)、细胞凋亡(形态学测量和TUNEL测定的凋亡指数)和环氧化酶-2水平(免疫组织化学和qRT-PCR评估COX-2 mRNA)。公共卫生相关性:结直肠癌是美国重要的健康问题,是美国癌症死亡的第二大原因。该项目将评估姜黄素在结直肠癌高危患者中预防结直肠腺瘤(发展为结直肠癌的病变)的能力。姜黄素在亚洲长期被用作香料,被认为是一种安全的食品添加剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCIS M GIARDIELLO其他文献
FRANCIS M GIARDIELLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCIS M GIARDIELLO', 18)}}的其他基金
Biofilm Epidemiology and Mechanisms in Colon Cancer
结肠癌生物膜流行病学和机制
- 批准号:
9313210 - 财政年份:2016
- 资助金额:
$ 21.26万 - 项目类别:
Biofilm Epidemiology and Mechanisms in Colon Cancer
结肠癌生物膜流行病学和机制
- 批准号:
9106285 - 财政年份:2016
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8545682 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8874342 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
7655272 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8698339 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8136627 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8652528 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
Curcumin chemoprevention in familial adenomatous polyposis
姜黄素化学预防家族性腺瘤性息肉病
- 批准号:
8890793 - 财政年份:2010
- 资助金额:
$ 21.26万 - 项目类别:
CORE--COLORECTAL AND PANCREATIC CANCER PATIENT REGISTRY
核心——结直肠癌和胰腺癌患者登记
- 批准号:
6300469 - 财政年份:2000
- 资助金额:
$ 21.26万 - 项目类别:
相似海外基金
Roles for Adenomatous polyposis coli in colon injury prevention and wound healing
腺瘤性大肠杆菌在预防结肠损伤和伤口愈合中的作用
- 批准号:
10707443 - 财政年份:2022
- 资助金额:
$ 21.26万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10063347 - 财政年份:2020
- 资助金额:
$ 21.26万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10217057 - 财政年份:2020
- 资助金额:
$ 21.26万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10653134 - 财政年份:2020
- 资助金额:
$ 21.26万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10424450 - 财政年份:2020
- 资助金额:
$ 21.26万 - 项目类别:
The molecular mechanism of adenomatous polyposis coli-binding protein EB1 in HCC
腺瘤性息肉病大肠杆菌结合蛋白EB1在肝癌中的分子机制
- 批准号:
25430134 - 财政年份:2013
- 资助金额:
$ 21.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expressioon of Adenomatous Polyposis Coli protein in the mouse cochlea.
腺瘤性息肉病大肠杆菌蛋白在小鼠耳蜗中的表达。
- 批准号:
24592538 - 财政年份:2012
- 资助金额:
$ 21.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tumor suppressor adenomatous polyposis coli and breast carcinogenesis
抑癌性腺瘤性结肠息肉病与乳腺癌发生
- 批准号:
7234812 - 财政年份:2003
- 资助金额:
$ 21.26万 - 项目类别:
Inactivation model of human Adenomatous Polyposis Coli gene by using budding yeast in vivo.
利用芽殖酵母体内的人腺瘤性息肉病大肠杆菌基因失活模型。
- 批准号:
10470129 - 财政年份:1998
- 资助金额:
$ 21.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Immunohistochemical and molecular biological study on abnormality of adenomatous polyposis coli gene in oral cancer and premalignant lesion.
口腔癌及癌前病变中腺瘤性息肉病基因异常的免疫组织化学和分子生物学研究。
- 批准号:
07671962 - 财政年份:1995
- 资助金额:
$ 21.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)